FDA Investigator Celeta S Coves
Celeta S Coves has inspections in 1 countries as of 06 Nov 2023. Celeta S Coves has collaborated with a combined 1503 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
60
Last Inspection Date:
06 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aleta T Flores,
Alexander M Kay,
Ana Djurdjevic,
Anthony E Keller, RPh,
Anthony N Onianwa,
Arsen Karapetyan,
Bryan A Galvez,
Bryce A May,
Cara M Minelli,
Carol F Robinson,
Catherine J Laufmann,
Charles L Larson,
Comyar Shoghi,
Courtney N Long,
Creighton T Tuzon,
Deborah A Greco,
Decarlos A Gomez,
Dennis G Kawabata,
Diana M Rand,
Doretha M Tonkins,
Doretha M Wilson,
Dylan R Jock,
Edward D Harris,
Emily B Camire,
Eric W Anderson,
Eric Zhu,
Erma Zaimova,
Gabriel M Guevarra,
Gene D Arcy,
Gina C Collins,
Gloria J Baca, MS,
Graham N Giesen,
James D Hildreth,
Janet Pulver,
Jocelyn E Massey,
Ka L Wong,
Karen J Bak,
Kathleen B Swat,
Kathryn A Krentz,
Kelvin Cheung,
Kenneth S Boehnen,
Kimberly A Dux,
Kirtida Patel,
Laura E Garcia,
Lauren E Swantko,
Laurissa S Flowers,
Leonard H Lavi,
Lori J Silverstein,
Mark W Babbitt,
Mary Ewilkerson Brinsko,
Maxyne T Lam,
Michael A Blaine,
Mpris Inspector,
Naveen B Walker,
Nikisha M Bolden,
Peter Kessler, PhD,
Phillip M Pontikos,
Raymond W Brullo,
Rebecca T Davis,
Richard J Bashay,
Robert B Shibuya, MD,
Robert D Tollefsen,
Robert S Sweeton,
Sarah Forney,
Scott K Zika,
Seema S Singh,
Selene T Torres,
Shaquenta Y Perkins,
Shelley H Beausoleil,
Sonya L Karsik,
Stephen R Souza,
Steven E Porter, Jr,
Tania Y Hall,
Tawny L Colling,
Terrance L Thomas,
Thea C Grome,
Timothy P Lafave,
Tonia L Sawyer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vickie L Anderson,
Vien Q Le,
Virgilio F Pacio, CSO,
William J Foust,
Yvette Mlacour Davis,
Yvonne C Wilkes,
Yvonne T Lacour
Celeta S Coves's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more